PANBIO Trademark

Trademark Overview


On Wednesday, April 8, 2020, a trademark application was filed for PANBIO with the United States Patent and Trademark Office. The USPTO has given the PANBIO trademark a serial number of 79285587. The federal status of this trademark filing is REGISTERED as of Tuesday, June 8, 2021. This trademark is owned by Abbott Rapid Diagnostics International Subsidiary Unlimited Company. The PANBIO trademark is filed in the Chemical Products and Pharmaceutical Products categories with the following description:

Diagnostic kits comprising medical diagnostic bioreagents for testing blood, bodily fluid, nasal samples, oral samples and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic test strips for testing blood, human serum, plasma, bodily fluid, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations f...

Control preparations for in vitro diagnostic testing, screening, confirmation and analysis, namely, diagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical reagents, namely, solutions used in diagnostic test kits for laboratory or research purposes; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; diagnostic test kits comprised of reagents for use in diagnostic tests for laboratory or research use; diagnostic preparations for laboratory or research use; diagnostic test kits comprising reagents and assays for laboratory or research use; in vitro diagnostic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector bor...
panbio

General Information


Serial Number79285587
Word MarkPANBIO
Filing DateWednesday, April 8, 2020
Status700 - REGISTERED
Status DateTuesday, June 8, 2021
Registration Number6375117
Registration DateTuesday, June 8, 2021
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 23, 2021

Trademark Statements


Goods and ServicesDiagnostic kits comprising medical diagnostic bioreagents for testing blood, bodily fluid, nasal samples, oral samples and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; medical diagnostic test strips for testing blood, human serum, plasma, bodily fluid, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue for use in the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic reagents; diagnostic preparations for medical purposes; testing preparations for medical use, namely, diagnostic preparations; diagnostic tests for medical use, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic tests, namely, medical diagnostic test media in the form of strips, cassettes, cartridges, and cards for the detection, identification, confirmation, and monitoring of respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; in vitro medical diagnostic assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; in vitro medical diagnostic test kits consisting primarily of monoclonal antibodies, buffers, and reagents for use in disease testing; in vitro medical diagnostic test strips for use in the field of infectious disease; in vitro medical diagnostic reagents; in vitro immunochromatographic tests for medical use, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue; medical diagnostics tests for the detection, diagnosis, screening, and confirmation of infections, namely, medical diagnostic reagents and assays for testing of body fluids, blood, human serum, plasma, nasal swab specimens, nasopharyngeal swab specimens, oral specimens, oropharyngeal swab specimens, and tissue
Pseudo MarkPAN BIO
Goods and ServicesControl preparations for in vitro diagnostic testing, screening, confirmation and analysis, namely, diagnostic preparations for scientific or research use; diagnostic reagents and chemical reagents for laboratory or research purposes; chemical reagents, namely, solutions used in diagnostic test kits for laboratory or research purposes; chemically-treated nonmedical test strips for laboratory or research purposes for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections; diagnostic test kits comprised of reagents for use in diagnostic tests for laboratory or research use; diagnostic preparations for laboratory or research use; diagnostic test kits comprising reagents and assays for laboratory or research use; in vitro diagnostic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use; in vitro immunochromatographic tests, namely, chemical reagents and assays for testing for respiratory, community acquired, hospital acquired, sexual health, gastro-enteric, vector borne, blood borne pathogen, and tropical disease infections for laboratory or research use, other than for medical or veterinary use

Classification Information


International Class001 - Chemicals used in industry, science and photography, as well as in agriculture, horticulture and forestry; unprocessed artificial resins; unprocessed plastics; manures; fire extinguishing compositions; tempering and soldering preparations; chemical substances for preserving foodstuffs; tanning substances; adhesives used in industry.
US Class Codes001, 005, 006, 010, 026, 046
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code001
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateFriday, May 15, 2020
Primary Code005
First Use Anywhere DateNOT AVAILABLE
First Use In Commerce DateNOT AVAILABLE

Trademark Owner History


Party NameAbbott Rapid Diagnostics International Subsidiary Unlimited Company
Party Type30 - Original Registrant
Legal Entity Type79 - NOT AVAILABLE
AddressIE

Party NameAbbott Rapid Diagnostics International Subsidiary Unlimited Company
Party Type20 - Owner at Publication
Legal Entity Type79 - NOT AVAILABLE
AddressIE

Party NameAbbott Rapid Diagnostics International Subsidiary Unlimited Company
Party Type10 - Original Applicant
Legal Entity Type79 - NOT AVAILABLE
AddressIE

Trademark Events


Event DateEvent Description
Friday, January 5, 2024NEW REPRESENTATIVE AT IB RECEIVED
Monday, November 15, 2021FINAL DECISION TRANSACTION PROCESSED BY IB
Tuesday, September 28, 2021GENERIC MADRID TRANSACTION SENT TO IB
Tuesday, September 28, 2021GENERIC MADRID TRANSACTION CREATED
Wednesday, September 8, 2021FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
Tuesday, June 8, 2021REGISTERED-PRINCIPAL REGISTER
Tuesday, March 23, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, March 23, 2021PUBLISHED FOR OPPOSITION
Sunday, March 21, 2021NOTIFICATION PROCESSED BY IB
Wednesday, March 3, 2021NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
Wednesday, March 3, 2021NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
Wednesday, March 3, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, February 16, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 9, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 8, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 8, 2021TEAS RESPONSE TO OFFICE ACTION RECEIVED
Tuesday, August 25, 2020REFUSAL PROCESSED BY IB
Thursday, August 6, 2020NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
Thursday, August 6, 2020REFUSAL PROCESSED BY MPU
Wednesday, July 1, 2020NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
Tuesday, June 30, 2020NON-FINAL ACTION WRITTEN
Thursday, June 25, 2020ASSIGNED TO EXAMINER
Tuesday, May 19, 2020APPLICATION FILING RECEIPT MAILED
Friday, May 15, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, May 14, 2020SN ASSIGNED FOR SECT 66A APPL FROM IB